Free Trial
LON:CREO

Creo Medical Group (CREO) Share Price, News & Analysis

Creo Medical Group logo
GBX 13.67 -0.08 (-0.61%)
As of 09:54 AM Eastern

About Creo Medical Group Stock (LON:CREO)

Key Stats

Today's Range
13.66
14
50-Day Range
12.25
14.48
52-Week Range
9.22
37
Volume
20,834 shs
Average Volume
1.11 million shs
Market Capitalization
£55.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.tc pixel
Creo Medical Updates Shareholder Notification
See More Headlines

CREO Stock Analysis - Frequently Asked Questions

Creo Medical Group's stock was trading at GBX 20.40 at the start of the year. Since then, CREO shares have decreased by 33.0% and is now trading at GBX 13.67.

Creo Medical Group PLC (LON:CREO) issued its quarterly earnings results on Monday, May, 19th. The company reported ($8.00) EPS for the quarter. Creo Medical Group had a negative trailing twelve-month return on equity of 41.79% and a negative net margin of 73.93%.

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), IQE (IQE), Lloyds Banking Group (LLOY), Barclays (BARC), BP (BP), BT Group (BT.A) and Coats Group (COA).

Company Calendar

Last Earnings
5/19/2025
Today
8/21/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:CREO
CIK
N/A
Fax
N/A
Employees
279
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (6.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£25.04 million
Net Margins
-73.93%
Pretax Margin
N/A
Return on Equity
-41.79%
Return on Assets
-20.09%

Debt

Debt-to-Equity Ratio
29.96
Current Ratio
3.24
Quick Ratio
2.19

Sales & Book Value

Annual Sales
£33.87 million
Price / Sales
1.64
Cash Flow
GBX 5.66 per share
Price / Cash Flow
2.43
Book Value
GBX 13.11 per share
Price / Book
1.05

Miscellaneous

Outstanding Shares
404,265,846
Free Float
N/A
Market Cap
£55.59 million
Optionable
Not Optionable
Beta
0.86
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:CREO) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners